Condensed Statement of Shareholders' Deficiency (Unaudited) - USD ($)	3 Months Ended
	Apr. 30, 2019	Apr. 30, 2018
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Balances - February 1, 2018	$ (655,736)	$ (569,705)
Net loss	(18,780)	(19,813)
Balances - April 30, 2018	$ (674,516)	$ (589,518)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Balances - February 1, 2018 (in shares)	1,899,575	1,899,575
Balances - February 1, 2018	$ 1,900	$ 1,900
Balances - April 30, 2018 (in shares)	1,899,575	1,899,575
Balances - April 30, 2018	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Balances - February 1, 2018	8,418,684	8,418,684
Balances - April 30, 2018	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Balances - February 1, 2018	(9,076,320)	(8,990,289)
Net loss	(18,780)	(19,813)
Balances - April 30, 2018	$ (9,095,100)	$ (9,010,102)